KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Change in Cash (2016 - 2025)

Historic Change in Cash for Global Medical REIT (GMRE) over the last 14 years, with Q3 2025 value amounting to $614000.0.

  • Global Medical REIT's Change in Cash rose 221724.14% to $614000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 105875.71%. This contributed to the annual value of $2.2 million for FY2024, which is 12868.97% up from last year.
  • According to the latest figures from Q3 2025, Global Medical REIT's Change in Cash is $614000.0, which was up 221724.14% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Global Medical REIT's Change in Cash ranged from a high of $6.0 million in Q2 2022 and a low of -$4.6 million during Q1 2022
  • Moreover, its 5-year median value for Change in Cash was $12000.0 (2024), whereas its average is -$48052.6.
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 80618.24% in 2022, then soared by 1355000.0% in 2025.
  • Global Medical REIT's Change in Cash (Quarter) stood at $890000.0 in 2021, then dropped by 3.37% to $860000.0 in 2022, then plummeted by 203.26% to -$888000.0 in 2023, then soared by 229.84% to $1.2 million in 2024, then plummeted by 46.75% to $614000.0 in 2025.
  • Its Change in Cash stands at $614000.0 for Q3 2025, versus $1.6 million for Q2 2025 and -$1.4 million for Q1 2025.